Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

Post by gojotv!on Apr 08, 2021 3:37pm
118 Views
Post# 32958330

I'm guessing it's been quiet because...

I'm guessing it's been quiet because......investors are checking their accounts to see what they can free up to buy more here.
I know that's what I did earlier today.
Good financials, growing profits, frugal management, recent reverse-split has shrunken the share float, first to market with a multi-cancer blood panel and the first couple of thousand patients already lined up, acquired our own source of demand and follow-up capacity, an employer group strategy in the works, a toehold in the rapidly growing telehealth market, the list goes on and on...
Very happy with my choice. It sure smells like money to me!
GLTAll Investors!

<< Previous
Bullboard Posts
Next >>